Astrazeneca PLC (AZN) News

Astrazeneca PLC (AZN)

Today's Latest Price: $53.85 USD

0.02 (-0.04%)

Updated Jun 5 7:23pm

Add AZN to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

Filter AZN News Items

AZN News Results

Event/TimeSymbolCompanyNews DetailStartEndChangePOWR Rating
Loading, please wait...

Latest AZN News From Around the Web

Below are the latest news stories about Astrazeneca Plc that investors may wish to consider to help them evaluate AZN as an investment opportunity.

AstraZeneca inks more coronavirus vaccine distribution deals

AstraZeneca (AZN) says it signed new agreements aimed at broadening global distribution of a coronavirus vaccine being developed by Oxford University researchers.In one deal, AstraZeneca says it will receive $750M from the Coalition for Epidemic Preparedness Innovations to manufacture and allocate 300M doses on a "no-profit" basis for a global...

Seeking Alpha | June 5, 2020

AstraZeneca inks deal with Accent Therapeutics to develop novel cancer therapeutics

Accent Therapeutics and AstraZeneca (AZN) will collaborate to discover, develop and commercialize transformative therapeutics targeting RNA-modifying proteins for the treatment of cancer. Under the terms of agreement, Accent will be responsible for research, development and commercialization activities for a nominated preclinical program through to the end of Phase I clinical...

Seeking Alpha | June 4, 2020

AstraZeneca boosts potential vaccine supply to 2bn

The drugs giant says it can double the production of a potential vaccine after backing by Bill Gates.

BBC | June 4, 2020

AstraZeneca doubles capacity for potential Covid-19 vaccine to 2bn doses

Company will increase manufacturing capability after striking additional deal worth £595m

The Guardian | June 4, 2020

Indian pharma joins AstraZeneca to supply 1 billion doses of Oxford coronavirus vaccine

Over 100 vaccines are currently in the race to end the Covid-19 pandemic

Khaleej Times | June 4, 2020

Drug firm AstraZeneca doubles coronavirus vaccine manufacturing capacity

Drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to two billion doses in a handful of deals involving Microsoft billionaire Bill Gates that guarantee early supply to lower income countries.

BreakingNews Ireland (Feed) | June 4, 2020

Astrazeneca agrees deals to produce 2bn coronavirus vaccine doses

CityAM - Drugs giant Astrazeneca has made deals that will mean it can deliver 2bn doses of Oxford University’s potential coronavirus vaccine,

City AM | June 4, 2020

Ex-FDA Chief On White House's Coronavirus Vaccine Shortlist: 'They Chose Very Novel Platforms'

The Trump administration is prioritizing five COVID-19 vaccine programs, but ex-FDA chief Dr. Scott Gottlieb said the White House needs to spread its bets. What Happened The Trump administration is betting that five companies have the highest chance of producing a working vaccine against COVID-19. They are: AstraZeneca plc (NYSE: AZN ), Johnson & Johnson (NYSE: JNJ ), Merck & Co, Inc. (NYSE: MRK ), Moderna Inc (NASDAQ: MRNA ) and Pfizer Inc. (NYSE: PFE ). As part of the public-private partnership, the government will prioritize clinical … Full story available on

Benzinga | June 4, 2020

The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peak (Biotech Stocks Hitting 52-week Highs June 3) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Black Diamond Therapeutics Inc (NASDAQ: BDTX ) Fortress Biotech (NASDAQ: FBIO ) Imara Inc (NASDAQ: IMRA ) Inari Medical Inc (NASDAQ: NARI ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Kala Pharmaceuticals Inc (NASDAQ: KALA ) Keros Therapeutics Inc (NASDAQ: KROS ) ORIC Pharmaceuticals Inc (NASDAQ: ORIC ) Phathom Pharmaceuticals Inc (NASDAQ: PHAT ) Pliant Therapeutics Inc (NASDAQ: PLRX ) (went public Wednesday) Protara Therapeutics Inc (NASDAQ: TARA ) Qiagen NV (NYSE: QGEN ) Turning Point Therapeutics Inc (NASDAQ: TPTX ) United Therapeutics Corporation (NASDAQ:...

Benzinga | June 4, 2020

AstraZeneca doubles coronavirus vaccine production capacity

British drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to 2 billion doses in a handful of deals involving Microsoft billionaire Bill Gates that guarantee early supply to lower-income countries. The deals with epidemic response group CEPI and vaccine alliance GAVI are backed by the World Health Organization and aim to quell…

New York Post | June 4, 2020

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8669 seconds.